Results 301 to 310 of about 3,164,979 (351)
Some of the next articles are maybe not open access.

Chronic migraine

BMJ, 2014
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
H C, Diener   +4 more
openaire   +4 more sources

Chronic migraine

Revue Neurologique, 2013
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
  +5 more sources

Headache characteristics and burden from chronic migraine with medication overuse headache: Cross‐sectional observations from the Medication Overuse Treatment Strategy trial

Headache, 2021
To describe headache characteristics, medication use, disability, and quality of life in a large patient cohort from the United States who have chronic migraine (CM) and medication overuse headache (MOH).
T. Schwedt   +12 more
semanticscholar   +1 more source

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.

Lancet Neurology, The, 2017
S. Tepper   +9 more
semanticscholar   +3 more sources

OnabotulinumtoxinA for Chronic Migraine

Headache: The Journal of Head and Face Pain, 2012
In 1992, Binder, a facial plastic surgeon in Los Angeles, first noted migraine improvement in a patient he was injecting with onabotulinumtoxinA for wrinkles.At the American Headache Society meeting in 1998, Binder and colleagues presented the first poster on onabotulinumtoxinA treatment in patients with migraine.
Andrew, Blumenfeld, Randolph W, Evans
openaire   +3 more sources

Chronic Infections and Migraine

Headache: The Journal of Head and Face Pain, 2004
Chronic infections and ...
Candelli, Marcello   +3 more
openaire   +3 more sources

Treatment of Chronic Migraine

Current Pain and Headache Reports, 2010
Chronic migraine is defined in different ways. The most commonly used definition is headache on more than 15 days per month in patients with migraine. Chronic migraine is difficult to treat and requires a multidisciplinary approach. Only two pharmacological treatments have been shown to be effective in placebo-controlled randomized trials: topiramate ...
Diener, Hans Christoph   +2 more
openaire   +3 more sources

Emerging treatment for chronic migraine and refractory chronic migraine

Expert Opinion on Emerging Drugs, 2012
Chronic migraine (CM), the suffering of 15 or more headache days with at least 8 of these migraine days, afflicts 1.3% - 5.1% of the global population. CM is the most common disorder faced by experts in tertiary headache centers. When resistant to conventional medical treatment and prophylactic medication this condition is known as refractory chronic ...
Luana Lionetto   +10 more
openaire   +3 more sources

Chronic migrainous vertigo

Journal of Clinical Neuroscience, 2004
A series of 16 subjects is described who presented with chronic vertigo that was thought to be migrainous in nature. The vertigo occurred on a daily basis and had been present for six months or more. Common symptoms included motion-induced dizziness, positional vertigo and motion sensitivity. Investigations were frequently normal apart from the finding
openaire   +2 more sources

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

Cephalalgia, 2020
Introduction Acute medication overuse is prevalent in patients with migraine. Methods In three phase 3, double-blind, randomized, placebo-controlled studies, patients with episodic migraine (EVOLVE-1 and EVOLVE-2) or chronic migraine (REGAIN) were ...
D. Dodick   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy